Erlotinib Tablet is a medicine that is used for the treatment of Non-Small Cell Lung Cancer, Chemotherapy, Pancreatic Cancer and other conditions.
Erlotinib Tablet contains Erlotinib as an active ingredient.
Erlotinib Tablet works by inhibiting the activity of protein to prevent the growth and spread of cancer cells.
Detailed information related to Erlotinib Tablet's uses, composition, dosage, side effects and reviews is listed below.
Erlotinib Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:
· Non-Small Cell Lung Cancer
· Pancreatic Cancer
Erlotinib Tablet improves the patient's condition by performing the following functions:
· Inhibiting the activity of protein to prevent the growth and spread of cancer cells.
Erlotinib Tablet is composed of the following active ingredients (salts)
· Erlotinib (100Mg)
Please note that this medicine may be available in various strengths for each active ingredient listed above.
The following is a list of possible side-effects that may occur from all constituting ingredients of Erlotinib Tablet. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.
· Dry Skin
Before using this drug, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side-effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.
· Breathing difficulty
· Contact lenses
· Increased eye watering
· Intolerance to some sugars
· Liver or kidney problems
· Loss of appetite
The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:
Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.
Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.
North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .
Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.
OCEANIA: Australia, New Zealand, Fiji, etc.
Zoledronic Acid Injection
Sunitinib Malate Capsules
Estramustine Phosphate Capsules
Abiraterone Acetate Tablets
Tamoxifen Citrate Tablets
Vinblastine Sulphate Injection
Sorafenib Tosylate Tablets
Erythropoietin Prefilled Syringe Injection
Vincristine Sulphate Injection